Retrospective study comparing three approaches for keloids: surgery + radiotherapy, surgery + pharmacological injection, and surgery alone

一项回顾性研究比较了三种治疗瘢痕疙瘩的方法:手术联合放射治疗、手术联合药物注射治疗和单纯手术治疗。

阅读:1

Abstract

OBJECTIVE: To investigate the differential efficacy of various treatment modalities adjunct to surgical excision of keloids and to analyze prognostic factors influencing outcomes. METHODOLOGY: A retrospective observational study approach was employed. Clinical data from 121 patients with keloids who met the inclusion criteria were collected for analysis of clinical characteristics and evaluation of treatment efficacy. The patients were categorized into three groups based on the adjuvant treatment modalities utilized post-surgical excision of keloids: surgical + radiotherapy group (group A), surgical + radiotherapy + pharmacological injection group (group B), and surgical group (group C). Factors potentially influencing treatment outcomes-such as treatment modality, gender, age, lesion distribution, lesion size, duration of the condition, and prior treatments-were subjected to a statistical analysis. Significant risk factors were identified through univariate analysis. RESULTS: The efficacy rates for group A, group B, and group C were 93.88%, 87.04%, and 55.56%, respectively. Statistical analysis indicated that age and treatment modality were significant risk factors for recurrence. CONCLUSION: The application of radiotherapy post-surgery, or a combination of radiotherapy and pharmacological injections postoperatively, has been demonstrated to significantly reduce the recurrence rate of keloids. Conversely, the efficacy of treatments that solely rely on surgery is comparatively lower. For elderly patients, early intervention upon the manifestation of clinical symptoms is strongly advocated, with a preference for adjunctive postoperative radiotherapy to mitigate the risk of recurrence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。